Farletuzumab Ecteribulin [2407465-18-1]
82929
TargetFOLR1
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameFarletuzumab Ecteribulin [2407465-18-1]
- Delivery Days Customer23
- CAS Number2407465-18-1
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID2348
- Target nameFOLR1
- Target descriptionfolate receptor alpha
- Target synonymsFBP, FOLR, FRalpha, NCFTD, folate receptor alpha, FR-alpha, KB cells FBP, adult folate-binding protein, folate binding protein, folate receptor 1 (adult), folate receptor, adult, ovarian tumor-associated antigen MOv18
- Protein IDP15328
- Protein NameFolate receptor alpha
- Scientific DescriptionFarletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.1,2
- Storage Instruction-80°C
- UNSPSC41116161
- SpeciesHuman





